Primary Results of the EVOLVE Short DAPT Study Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent Article

Industry Collaboration International Collaboration

cited authors

  • Kirtane, Ajay J.; Stoler, Robert; Feldman, Robert; Neumann, Franz-Josef; Boutis, Loukas; Tahirkheli, Naeem; Toelg, Ralph; Othman, Islam; Stein, Bernardo; Choi, James W.; Windecker, Stephan; Yeh, Robert W.; Dauerman, Harold L.; Price, Matthew J.; Underwood, Paul; Allocco, Dominic; Meredith, Ian; Kereiakes, Dean J.

Publication Date

  • March 1, 2021

webpage

category

keywords

  • aspirin
  • everolimus
  • percutaneous coronary intervention
  • stent
  • thrombosis

volume

  • 14

issue

  • 3